ArticleAnalytical chemistry2026
LCMS-Net: Deep Learning for Raw High Resolution Mass Spectrometry Data Applied to Forensic Cause-of-Death Screening.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a mobile application to estimate time of death based on the compound method.International journal of legal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current preprocessing workflows for untargeted metabolomics using liquid chromatography-high resolution mass spectrometry (LC-HRMS) are time-consuming and require significant domain knowledge. Furthermore, they lack reproducibility or may fail to detect some metabolites entirely. We introduce LCMS-Net, an end-to-end deep learning model for the analysis of LC-HRMS data, to address these challenges. LCMS-Net mitigates the need for manual data preprocessing by operating directly on the raw LC-HRMS data and explicitly modeling its spatial properties. The effectiveness of this fully automated workflow is shown through two case-studies, cause-of-death (CoD) screening and colon cancer detection. For the cause-of-death screening task, LCMS-Net achieved a 9% improvement in F1-score compared to the previous state-of-the-art model (OPLS-DA). For the colon cancer detection task, LCMS-Net achieved an F1-score improvement of 1.8% compared to the previous state-of-the-art model (DeepMSProfiler). Furthermore, LCMS-Net significantly reduces batch effects that are a common source of bias in metabolomics data analyses. This was shown by using a training and test set from different measurement instruments, where the performance only differed by at most 3% as to using data from the same instrument. Compared to other end-to-end deep learning methods for LC-HRMS data, LCMS-Net is also structurally simpler and does not rely on pretraining, which makes it faster and computationally more efficient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.